Exvivo Labs, Inc.

EXVIVO

Transdermal patches for use in medical diagnostics to treat allergies, infectious diseases, neurological disorders, cardiovascular diseases, skin disorders, cancers, and endocrine disorders, and monitor general health biomarkers; biochemical assays for testing body fluids for use in medical diagnostics, point-of-care diagnostics, and pharmacy diagnostics;Medical equipment, namely, microneedles for medical use; medical devices for use in microfluidics, namely, paper-based microfluidics and microfluidic chips; finger prick needles;Medical device research and development services; research and development services in the area of in vitro diagnostic (IVD) platforms; point-of-care medical device research and development services; research and development services in the area of allergy testing; research and development services in the area of transdermal pharmaceutical drug delivery; research and development services in the area of transdermal immunotherapy delivery;